Rifaximin Use in Severe Alcoholic Hepatitis
Clinical trial NCT02485106 · UNKNOWN
Trial details
- NCT number
- NCT02485106
- Sponsor
- Saint Vincent's Hospital, Korea
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-12-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.